| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5605056 | International Journal of Cardiology | 2017 | 7 Pages |
Abstract
Our results suggest that galectin-3 is an independent predictor of all-cause and cardiovascular mortality in SSc. Validation studies are required to establish whether galectin-3 may be proposed as simple biomarker for identifying patients with high mortality risk in SSc.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Réka Faludi, Gabriella Nagy, Margit TÅkés-Füzesi, Krisztina Kovács, László Czirják, András Komócsi,